Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02109835Unknown

Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects

Role: collaborator

NCT01988454Completed

Characterization of Dyslipidemia in Adolescent Obesity

Role: lead

NCT01998867Unknown

Fasting Predictors of OGTT and MMTT Response

Role: lead

NCT01985048Unknown

Cardiometabolic Risk in Cardiac Rehab

Role: lead

NCT01993914Completed

Prevalence of MTHFR Polymorphisms in Venous Disease

Role: lead

All 5 trials loaded